We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Reata Pharmaceuticals Inc | NASDAQ:RETA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 172.36 | 189.75 | 172.36 | 0 | 01:00:00 |
From May 2021 to May 2024
By Josh Beckerman
Reata Pharmaceuticals Inc. shares were recently down 30% to $38 after hours after the company received a negative opinion from a Food and Drug Administration advisory committee for its new drug application for bardoxolone methyl.
Reata shares were halted all day Wednesday.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
December 08, 2021 19:10 ET (00:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Reata Pharmaceuticals Chart |
1 Month Reata Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
